BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16674021)

  • 1. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
    Cole LA; Sutton JM
    J Reprod Med; 2006 Mar; 51(3):217. PubMed ID: 16674021
    [No Abstract]   [Full Text] [Related]  

  • 2. Selecting an appropriate hCG test for managing gestational trophoblastic disease and cancer.
    Cole LA; Sutton JM
    J Reprod Med; 2004 Jul; 49(7):545-53. PubMed ID: 15305826
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gestational trophoblastic diseases: 4. Presentation with persistent low positive human chorionic gonadotropin test results.
    Cole LA; Khanlian SA; Giddings A; Butler SA; Muller CY; Hammond C; Kohorn E
    Gynecol Oncol; 2006 Aug; 102(2):165-72. PubMed ID: 16631243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of gestational trophoblastic disease and other cases with low serum levels of human chorionic gonadotropin.
    Khanlian SA; Cole LA
    J Reprod Med; 2006 Oct; 51(10):812-8. PubMed ID: 17086809
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The need for an hCG assay that appropriately detects trophoblastic disease and other hCG-producing cancers.
    Cole LA; Kohorn EI
    J Reprod Med; 2006 Oct; 51(10):793-811. PubMed ID: 17086808
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Importance of accurate human chorionic gonadotropin measurement in the treatment of gestational trophoblast disease and testicular cancer.
    Mitchell H; Bagshawe KD; Newlands ES; Savage P; Seckl MJ
    J Reprod Med; 2006 Nov; 51(11):868-70. PubMed ID: 17165431
    [No Abstract]   [Full Text] [Related]  

  • 7. Gestation trophoblastic diseases: management of cases with persistent low human chorionic gonadotropin results.
    Cole LA; Kohorn E; Smith HO
    Obstet Gynecol Clin North Am; 2005 Dec; 32(4):615-26. PubMed ID: 16310675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. What we know about low-level hCG: definition, classification and management.
    Kohorn EI
    J Reprod Med; 2004 Jun; 49(6):433-7. PubMed ID: 15283049
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gestational trophoblastic diseases: 2. Hyperglycosylated hCG as a reliable marker of active neoplasia.
    Cole LA; Butler SA; Khanlian SA; Giddings A; Muller CY; Seckl MJ; Kohorn EI
    Gynecol Oncol; 2006 Aug; 102(2):151-9. PubMed ID: 16631241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The diagnosis of gestational trophoblastic disease in early pregnancy: implications for screening, counseling and management.
    Sebire NJ
    Ultrasound Obstet Gynecol; 2005 May; 25(5):421-4. PubMed ID: 15846756
    [No Abstract]   [Full Text] [Related]  

  • 11. Postevacuation hCG levels and risk of gestational trophoblastic neoplasia among women with partial molar pregnancies.
    Growdon WB; Wolfberg AJ; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
    J Reprod Med; 2006 Nov; 51(11):871-4. PubMed ID: 17165432
    [TBL] [Abstract][Full Text] [Related]  

  • 12. hCG measurement in gestational trophoblastic neoplasia: a critical appraisal.
    Hancock BW
    J Reprod Med; 2006 Nov; 51(11):859-60. PubMed ID: 17165429
    [No Abstract]   [Full Text] [Related]  

  • 13. USA hCG reference service, 10-year report.
    Cole LA; Laidler LL; Muller CY
    Clin Biochem; 2010 Aug; 43(12):1013-22. PubMed ID: 20493830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detecting and monitoring trophoblastic disease. New perspectives on measuring human chorionic gonadotropin levels.
    Cole LA; Kohorn EI; Kim GS
    J Reprod Med; 1994 Mar; 39(3):193-200. PubMed ID: 8035374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of persistent, unexplained, low-level human chorionic gonadotropin elevation: a report of 5 cases.
    Hwang D; Hancock BW
    J Reprod Med; 2004 Jul; 49(7):559-62. PubMed ID: 15305828
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical value of tumor markers in gestational trophoblastic diseases.
    Ahmad AE; Dehaghani AS; Shaker M; Fattahi MJ
    J Reprod Med; 2008 Dec; 53(12):930-4. PubMed ID: 19160651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low risk of relapse after achieving undetectable HCG levels in women with partial molar pregnancy.
    Wolfberg AJ; Growdon WB; Feltmate CM; Goldstein DP; Genest DR; Chinchilla ME; Berkowitz RS; Lieberman ES
    Obstet Gynecol; 2006 Aug; 108(2):393-6. PubMed ID: 16880311
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Easy fix for clinical laboratories for the false-positive defect with the Abbott AxSym total beta-hCG test.
    Cole LA; Khanlian SA
    Clin Biochem; 2004 May; 37(5):344-9. PubMed ID: 15087248
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Trophoblastic diseases].
    ten Kate-Booij MJ; Lok CA; Verheijen RH; Massuger LF; van Trommel NE
    Ned Tijdschr Geneeskd; 2008 Oct; 152(41):2219-24. PubMed ID: 19009808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The classification, functions and clinical use of different isoforms of HCG.
    Stenman UH; Tiitinen A; Alfthan H; Valmu L
    Hum Reprod Update; 2006; 12(6):769-84. PubMed ID: 16877746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.